Back
Speaker illustration

Mr Or Levi

Ben-Gurion University of the Negev, Beer Sheva (Israel)

Presentations

BA6b9, a novel sk4 K + channel blocker, attenuates atrial fibrillation substrate in rats with reduced ejection fraction

Event: ESC Congress 2024

Topic: Antiarrhythmic Drug Treatment

Session: Clinical and experimental arrhythmia treatments

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources